Survey of Sexual Health in Cancer Patients
S&C
Sexual Health in Cancer Patients: a Survey and Pilot Study of Psychosexual Therapy as a Non-pharmacological Supportive Care
2 other identifiers
observational
200
1 country
1
Brief Summary
Sexual health, a vital aspect of the overall human health and a critical component of quality of life, can be negatively affected by cancer and cancer treatments. Although prevalence rates of sexual difficulties vary depending on several factors including primary diagnosis, treatment modality and methods of assessment, estimates rates are reported to range from 40% to 100%. Despite the abundant literature on sexuality and intimacy, communication about sexual health is often absent or inadequate between patients and health care providers. In this context, more research is needed to understand patients' priorities and needs for information about sexuality. The purpose of this study is to assess the main difficulties faced by patients in their sexual life and to evaluate patient's satisfaction after having followed sessions of psychosexual therapy proposed at Rafaël Institute, France. The survey will be conducted using questionnaires developed specifically for this study. All questions will be coded through a Likert scale from 1 (strongly disagree) to 7 (strongly agree). Responses to each question will be analyzed with higher mean scores (\>4) indicating main difficulties faced by patients in their sexual life. Patients will also express their positive or negative state of agreement regarding questions evaluating their satisfaction after following a program of psychosexual therapy. Approximately 200 patients will be invite to participated in this survey after provided oral consent.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 19, 2024
CompletedFirst Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
May 24, 2024
CompletedMay 29, 2024
May 1, 2024
1 month
May 20, 2024
May 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patients' satisfaction with their sexual lives
questionnaire
1 month
Secondary Outcomes (3)
identification of the main physiological and psychological difficulties encountered by patients in their sexual lives
1 month
patients perceived emotions
1 month
description of the impact of sex therapy sessions on the sexual health of the participants
1 month
Interventions
survey
Eligibility Criteria
Eligible participants will be adults aged 18 years old or older diagnosed with cancer and undergoing non-pharmacological supportive care during or after their standards cancer treatments at Rafael Institute
You may qualify if:
- cancer patients
- adults aged \> 18 years old
You may not qualify if:
- \<18years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institut Rafaellead
Study Sites (1)
Institute Rafaël
Levallois-Perret, Institut Rafael, 92300, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2024
First Posted
May 24, 2024
Study Start
April 19, 2024
Primary Completion
May 19, 2024
Study Completion
May 19, 2024
Last Updated
May 29, 2024
Record last verified: 2024-05